TP53 and melanoma: However, since we found the chemo-sensitizing effect of TAp73 knockdown in melanoma cells with different TP53 mutational status and activity, it is to be assumed that TAp73 acts independently of its crosstalk with p53-mediated signalling in the protection of melanoma cells to cisplatin or carboplatin treatment.